Prosecution Insights
Last updated: November 04, 2026
Application No. 18/224,955

PILLOW, BLANKET, TOPPER, MATTRESS AND/OR OVERLAY FOR CALMING A USER'S AUTONOMIC NERVOUS SYSTEM

Final Rejection §103
Filed
Jul 21, 2023
Priority
Jul 22, 2022 — DE 102022118391.2
Examiner
KURILLA, ERIC J
Art Unit
3619
Tech Center
3600 — Transportation & Electronic Commerce
Assignee
Zweizehn GmbH & Co. Kg
OA Round
2 (Final)
71%
Grant Probability
Favorable
3-4
OA Rounds
0m
Est. Remaining
96%
With Interview

Examiner Intelligence

Grants 71% — above average
71%
Career Allowance Rate
578 granted / 818 resolved
+18.7% vs TC avg
Strong +26% interview lift
Without
With
+25.8%
Interview Lift
resolved cases with interview
Typical timeline
2y 3m
Avg Prosecution
25 currently pending
Career history
850
Total Applications
across all art units

Statute-Specific Performance

§101
0.9%
-39.1% vs TC avg
§103
42.4%
+2.4% vs TC avg
§102
23.0%
-17.0% vs TC avg
§112
26.1%
-13.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 818 resolved cases

Office Action

§103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1, 3-5, and 11 is/are rejected under 35 U.S.C. 103 as being unpatentable over Tan (CN 103169314). Regarding Claim 1, Tan discloses a pillow, blanket, topper, mattress, and/or overlay (“pillow”, see English Translation provided by Applicant) for calming a vegetative nervous system of a user, comprising at least one filling chamber (inside of pillow); at least one filling material (“pillow core filling can have other soft materials such as cotton and kapok”) disposed within the filling chamber ; and at least one filling region (“medicine bag”) within the filling chamber, the filling region being formed by at least one interspace that is at least partially delimited by the filling material (“fill the medicine package into the pillow core”), wherein the interspace is at least partially formed by, or at least partially contains, a cannabinoid- containing material and/or a THC-containing material (“Hemp contains cannabinoids […] mainly including tetrahydrocannabinol”), wherein the cannabinoid-containing material and/or THC-containing material comprises dried hemp plant material (cut and dried hemp plant) and has a THC content below 0.3% by weight, and wherein the filling material is substantially free of the cannabinoid-containing material and/or THC-containing material (“the hemp plants can be fixed in the medicine bag without being scattered in the pillow core”). The excerpt from the English translation mainly relied upon for the rejection is copied below: PNG media_image1.png 650 954 media_image1.png Greyscale Tan fails to explicitly disclose the dried hemp plant material has a THC content below 0.3% by weight. As noted by Applicant in their remarks filed September 22nd, 2026 and the attached “Changes to the Statutory Definition of Hemp and Implications for Agricultural Policy”, a THC content below 0.3% by weight characterizes the material as industrial hemp plant material without an intoxicating THC load. Abiding by a law or meeting regulatory standards for a certain classification terminology is within ordinary skill in the art. The motivation to meet regulatory standards would be to avoid legal issues. Regarding Claim 3, Tan discloses wherein the dried hemp plant material comprises a cannabis plant flower (see “Example Three”) and at least one additional plant part selected from the group consisting of a flower stalk, petals, and a shoot axis (see “Example Three”). Regarding Claim 4, Tan discloses wherein the dried hemp plant material comprises a flower stalk, petals, and a cannabis plant flower (see “Example Three”). Regarding Claim 5, Tan discloses wherein the dried hemp plant material comprises whole hemp plants (see “cut fresh hemp plants”), each whole hemp plant comprising at least a shoot axis with a flower stalk, petals, and a flower (see “Example Three”). Regarding Claim 11, Tan discloses wherein the dried hemp plant material comprises a cannabis plant flower (see “Example Three”). Claim(s) 2 and 8 is/are rejected under 35 U.S.C. 103 as being unpatentable over Tan (CN 103169314) in view of Peters (US 6,430,764). Regarding Claim 2, Tan fails to explicitly disclose wherein the filling region is completely surrounded by the filling chamber. Peters teaches wherein a filling region (within 12) is completely surrounded by a filling chamber (within 11, see Fig. 2). Tan and Peters are analogous art because they are from the same field of endeavor, i.e. pillows. It would have been obvious to one having ordinary skill in the art at the time the invention was filed to modify the pillow construction of Tan with the filling region being completely surrounded by the filling chamber as taught by Peters. The motivation would have been to prevent the filling region of Tan from shifting, thus preventing a user from substantially feeling it when lying on the pillow. Regarding Claim 8, Tan fails to disclose wherein the cannabinoid-containing material and/or THC-containing material is disposed in pockets of the filling chamber, the pockets being delimited by chamber walls that separate the cannabinoid-containing material and/or THC-containing material from the filling material (emphasis added). Tan discloses a singular pocket. Peters teaches herbal material (14) placed in pockets (12 is described as “one or more pouch members”) of a filling chamber (within bag 11), the pockets being delimited by chamber walls (each pocket 12 contains its own chamber wall) that separate the herbal material (see Fig. 2). It would have been obvious to one having ordinary skill in the art at the time the invention was filed to modify the singular pocket of Tan with the multiple pockets of Peters. The motivation would have been to provide a greater aroma effect. Allowable Subject Matter Claims 6, 7, and 10 objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. The following is a statement of reasons for the indication of allowable subject matter: Regarding Claim 6, Tan fails to disclose wherein the filling material is at least partly a filling layer material comprising a plurality of mutually adjacent layers, and comprising in particular a quilted fabric, and wherein the cannabinoid-containing material and/or THC-containing material is at least partly introduced between at least two mutually adjacent layers such that the filling region is at least partly formed between or through the two adjacent layers. Peters teaches wherein a filling material (13) is at least partly a filling layer material comprising a plurality of mutually adjacent layers (13), and comprising a quilted fabric, and wherein herbs (14) are at least partly introduced between at least two mutually adjacent layers such that the filling region (within 12) is at least partly formed between or through the two adjacent layers. Quilted fabrics are well-known throughout the art (see e.g. quilted mattress toppers” in Peterson and quilted blanket of Tielkes (DE 3333270), however further modifying the potential modifying reference Peterson as required by the claim would be impermissible hindsight reconstruction. Response to Arguments Applicant’s arguments with respect to claim(s) 1-8 and 10-11 have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to ERIC J KURILLA whose telephone number is (571)270-7294. The examiner can normally be reached Monday-Thursday 7AM-6PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Anita Coupe can be reached at 571-270-3614. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ERIC J KURILLA/ Primary Examiner, Art Unit 3619
Read full office action

Prosecution Timeline

Jul 21, 2023
Application Filed
Apr 22, 2026
Non-Final Rejection mailed — §103
Jun 11, 2026
Examiner Interview Summary
Sep 22, 2026
Response Filed
Oct 26, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12778824
MEDICAL BED FRAME WITH ADJUSTABLE WIDTH AND LENGTH
2y 12m to grant Granted Nov 03, 2026
Patent 12778338
MACHINE FOR DISPENSING AN INFUSION BEVERAGE
2y 10m to grant Granted Nov 03, 2026
Patent 12766061
INTERFACE MOVEABLY INTERCONNECTING SURGICAL TABLE AND SURGICAL CART
2y 5m to grant Granted Oct 20, 2026
Patent 12765690
POCKETED SPRINGS ASSEMBLY, MATTRESS AND POCKETED SPRINGS ASSEMBLY MANUFACTURING METHOD
2y 0m to grant Granted Oct 20, 2026
Patent 12766058
STEP STOOL AND METHOD OF USE
1y 12m to grant Granted Oct 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
71%
Grant Probability
96%
With Interview (+25.8%)
2y 3m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 818 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month